Fresenius Medical Care AG (FMS)
Operates dialysis clinics and makes kidney treatment machines and medicines worldwide.
$24.78-0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-1.4%
The outlook
FMS is trading above both its 50- and 200-day moving averages, positioning it in the middle-to-upper range of its 52-week span. Analyst consensus sits at "Hold" with an average price target roughly 3% above the current level. The stock shows a leaning bullish technical backdrop, though analyst sentiment remains neutral overall.
What’s behind the score
Analyst consensusHold — 3.0 avg of 7 analysts
Price trendAbove its 50- & 200-day averages
52-week range62% of the way from its 52-week low to high
Price targetAvg target +3% vs current price
Analyst price target
~12-month · 7 analysts$25.61average target+3.4% vs now
Now $24.78
Low $18.12High $37.88
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$13.31B
52-wk high
$27.64
52-wk low
$20.02
50-day avg
$22.99
200-day avg
$23.43
Trailing P/E
13.3